Influenza :: Afluria influenza vaccine approved for upcoming influenza season

The U.S. Food and Drug Administration approved Afluria, an additional seasonal influenza vaccine for the immunization of people ages 18 and older. Afluria is intended to protect adults from influenza type A and type B flu viruses. Influenza is a contagious respiratory illness that can cause annual epidemics.

Bird Flu :: New research shows how H5N1 virus causes disease

H5N1 influenza, also known as avian influenza, is considered a major global threat to human health, with high fatality rates. While little had been known about the specific effects of H5N1 on organs and cells targeted by the virus, researchers at Beijing University, Columbia University Mailman School of Public Health, and SUNY Downstate report in the September 29, 2007 issue of the Lancet detailed studies of human H5N1 victims that shed light on the anatomic distribution of the virus and its pathogenesis.

Bird Flu :: New field-deployable biosensor detects avian influenza virus in minutes instead of days

Quick identification of avian influenza infection in poultry is critical to controlling outbreaks, but current detection methods can require several days to produce results. A new biosensor developed at the Georgia Tech Research Institute can detect avian influenza in just minutes. In addition to being a rapid test, the biosensor is economical, field-deployable, sensitive to different viral strains and requires no labels or reagents.

Bird Flu :: Lab-on-a-chip Device to Transform Field Testing for Avian Flu Virus, Singapore

Researchers at the Institute of Bioengineering and Nanotechnology (IBN), Institute of Molecular and Cell Biology (IMCB) and Genome Institute of Singapore (GIS) have successfully developed a miniaturized device that can be used to detect the highly pathogenic avian flu (H5N1) virus.